Orrick advised OKYO Pharma on the deal.OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO), a biotechnology company focused on the discovery and development of novel molecules to…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now